Skip to main content
MarketStoryBook

Becton, Dickinson and Company in 2 stories

The narratives BDX currently appears in, with its side and exposure in each.

Bull side

2 stories
  • GLP-1 Eats Everything

    BDX in “GLP-1 Eats Everything”

    FadingExposure: not rated yet

    Appetite suppression as a macro variable.

    Higher use of injectable obesity medicines expands the addressable market for pen needles and other drug-delivery components.

  • Managed Care's Margin Machine Breaks

    BDX in “Managed Care's Margin Machine Breaks”

    FadingExposure: not rated yet

    Rising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.

    Rising hospital admissions and treatment intensity increase consumption of its needles, catheters, medication-management products and laboratory supplies.

Bear side

0 stories

No bear-side stories for BDX yet.